Shares of medical cloud software firm Veeva Systems (VEEV) - Get Report were falling almost 6% on Tuesday afternoon after noted short seller Citron Research tweeted a short recommendation on the stock.
Veeva shares began the day trading at about $99 and were already falling when Citron published a tweet setting a price target of $65, saying that a "a market correction will hit $VEEV harder than any other SaaS name." Selling accelerated after the tweet, before recovering some ground. The broader markets were down about 3% on Tuesday on concerns about the U.S.-China trade deal and concerns over economic growth.
Veeva is still up almost 70% this year.